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Twenty-seven clinical and laboratory data and the 
subsequent clinical course of 93 consecutive adult pa-
tients who underwent orthotopic liver transplantation 
for various chronic advanced liver diseases were ana-
lyzed retrospectively to assess the risk factors of early 
major bacterial infection and death after the procedure. 
Forty-one patients (44%) had early major bacterial in-
fection during hospitalization for orthotopic liver trans-
plantation. The mortality rate was 70.7% in patients 
with early major bacterial infection and was 7.7% in 
patients without early major bacterial infection (p < 
0.001). Total serum bilirubin, total white blood cell 
count and polymorphonuclear cell count, IgG (all p < 
0.05) and plasma creatinine level (p < 0.001) were 
higher in patients that developed early major bacterial 
infection than in those who did not. By step-wise dis-
criminant analysis, the strongest risk factor for early 
major bacterial infection was the serum creatinine level, 
which achieved an accuracy of 69% for a creatinine 
level greater than 1.58 mg per dl. 
Seven variables (ascites, hepatic encephalopathy, el-
evated white blood and polymorphonuclear cell count, 
decreased helper to suppressor T cell ratio and elevated 
plasma creatinine and bilirubin levels) were associated 
with a significant increased risk for death. A step-wise 
discriminant analysis of these seven factors resulted in 
the demonstration of serum creatinine as the greatest 
risk factor for mortality. A preoperative serum creati-
nine either less than or greater than 1.72 mg per dl 
accurately predicts survival or death, respectively, in 
79% of cases. These data suggest that the baseline pre-
operative serum creatinine level provides the best indi-
cation of the short-term prognosis after liver transplan-
tation than does any other preoperatively obtained in-
dex of the patient's status. 
Orthotopic liver transplantation (OLTx) has dramat-
ically altered the otherwise fatal outcome for some pa-
tients with advanced chronic liver disease and has been 
reported to obtain a 70.8% survival in adult patients at 
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1 year after OL Tx (1). Because both economic and hu-
man resources are limited within the health care system 
of most countries and institutions, liver transplantation 
ideally should be restricted to those patients with the 
greatest possibility of survival after the procedure, so the 
selection of appropriate candidates for OL Tx has become 
an issue of considerable concern both for physicians and 
surgeons involved in the management of patients with 
advanced hepatic disease. 
In a recent series of adult patients with OLTx, 75% of 
the deaths occurred during the first 60 days post-
transplantation (2). In this series, infectious complica-
tions were the most common cause of death. Ninety per 
cent of the deaths due to infection following OLTx 
occurred during the first 60 days post-OLTx; 79% of 
these deaths were caused by bacterial infection. Thus, 
early bacterial infection appears to be the leading single 
cause of death after liver transplantation in adults. 
The purpose of the present study was to determine: (i) 
whether easily obtainable preoperative clinical and lab-
oratory data which can be obtained reasonably can iden-
tify patients who will develop early postoperative bacte-
rial infections and (ii) whether these same factors can 
serve as objective predictors of an early death in adult 
patients undergoing OL Tx. 
PATIENT POPULATION AND METHODS 
Ninety-three consecutive adult patients who received 128 
consecutive OL Tx procedures at the University of Pittsburgh 
between February, 1981 and January, 1984 were evaluated 
retrospectively. Twenty-two patients received 2 transplants 
while 3 patients had 3 consecutive OL Tx. Only those patients 
who survived the immediate postoperative period (24 hr) after 
OL Tx were included in the study. Thus, 7 patients who did not 
survive for 24 hr, either dying in the operating room or soon 
thereafter, were excluded from the analysis leaving 93 patients 
whose records were available for analysis. 
The facilities and details of our patient selection process, 
regimens for supportive care, OL Tx procedures and immuno-
suppression regimens have been described in detail elsewhere 
(3-5). In general, patients who were selected for transplantation 
were required to meet the following requirements based upon 
the nature of their primary disease: 
1. Chronic Advanced Liver Disease 
A. No medical or surgical options available except for 
transplantation. 
922 
-
• 
r 
,T 
VoL 6, No, 5,1986 PROGNOSIS WITH ORTHOTOPIC LIVER TRANSPLANTATION 923 
B, Two of, ;,,? :our fullowing criteria: 
(i) a bilirubin level> 15 mg per dl 
(iii an albumin level <2.5 gm per dl 
(iii) a prothrombin time >5 sec above control 
(iv) encephalopathy not responsive to dietary reo 
strictions, lactulose and neomycin or any com-
bination of these therapies, 
II, Hepatic Malignancy 
A. A tumor that was not resectable without hepatec-
tomy. 
B, No evidence of extrahepatic metastasis. 
III, Fulminant or Subacute Hepatic Failure 
A. In advanced Grade 3 or 4 encephalopathy, 
B, In the intensive care unit and on a respirator. 
All OL Tx recipients received comparable clinical management 
[rom the same medical and surgical teams throughout the study 
interval. 
Data were collected retrospectively from the patients' hos-
pital charts. Survival was recorded up to the day of discharge 
from the hospital. The data obtained on bacterial infection 
were recorded up to the sixtieth day post-OLTx or up to the 
date of discharge from hospital, whichever occurred earlier. 
Bacterial infections recognized after this closing date were 
excluded from the study. Thus, only data relevant to early 
major bacterial infections (EMBl) were collected. The diagnosis 
of EMBI was made using clinical and laboratory criteria. An 
EMBI was defined as any bacterial infection acquired during 
the patient's hospitalization after 0 L Tx or until the sixtieth 
day of posttransplantation, which resulted in a prolongation of 
the hospitalization, additional surgical procedures or death. 
Minor afebrile upper respiratory tract infections and catheter-
associated bacteriurias were excluded from study. Isolations of 
bacteria from throat, sputum, nasotracheal aspirates and sur-
gical drainage tubes which occurred without associated clinical 
abnormalities suggestive of infection were excluded from the 
analysis. The microorganisms which were isolated were iden-
tified using standard procedures in the clinical microbiological 
laboratory of Presbyterian-University Hospital, Pittsburgh, Pa. 
In seven patients with pneumonia, no bacterial agent was 
isolated but the pneumonia was thought to be of bacterial origin 
because of its improvement after the initiation of antimicrobial 
therapy. 
Twenty-seven clinical and biochemical variables were ob-
tained on each patient preoperatively and were evaluated. Sur-
viving and nonsurviving groups were divided into two sub-
groups: those who developed postoperative EMBI and those 
who did not. The clinically obtainable preoperatively items 
recorded included age, sex, underlying liver disease, presence 
of encephalopathy, ascites and esophageal varices, variceal 
bleeding (considered to have occurred any time during the 
perIod between the first complaint of disease and subsequent 
OL Tx), previous episodes of systemic sepsis or spontaneous 
bacterial peritonitis and any immunosuppressive therapy which 
was applied during the immediate 6 months prior to OLTx. 
NlUeteen biochemical variables were also obtained. These in-
C~uded: total protein, albumin, prothrombin time, total biliru-
bIn, transferrin, white blood cell (WBC) count, polymorpho-
nuclear (PMN) cell count and total lymphocyte count; total T 
lYmphocytes, total suppressor T cells, total helper T cells and 
the. ratio of helper to suppressor T lymphocytes present in 
penpheral blood; immunoglobulins (lgG, IgM and IgAl; com-
plement[C3, C., properdin factor B (PFB)], and serum comple-
ment total capacity (CHlOO). In 31 patients, one of the follow-
~eg variables had not been recorded: T and B cells (31 patients); 
100 (31 patients); PFB (8 patients); WBC and differential 
(7 patients), and total proteins and albumin (4 patients). All 
~hnables represent the last laboratory value obtained prior to 
e performance of the OL Tx. 
Quantitative data are expressed as mean ± S.E. Statistical 
comparisons between groups for these variables were made 
using x2 analysis to compare proportions and the unpaired 
Student's t test or U Mann-Whitney test to compare means. A 
p value less than 0.05 was considered to be significant. Those 
variables that were related significantly to EMBI or to death 
by themselves were included subsequently in a step-wise dis-
criminant analysis with the presence or absence of EMBI, or 
the short-term final outcome (alive or death) after OL Tx as 
the outcome-dependent variable, respectively (6, 7). Because 
total T and B lymphocyte levels in peripheral blood and CH100 
data were unavailable for many of the patients studied, these 
data were not assessed by this method. 
RESULTS 
The study population of 93 patients included 37 men 
and 56 women whose ages ranged from 18 to 53 years, 
with an average of 32 ± 1 year. Seventeen of these 93 
patients (18%) had had at least one episode of major 
bacterial sepsis before transplantation. Twenty-three 
(25%) had received immunosuppressive therapy (pred-
nisone, azathioprine or D-penicillamine) during the 6 
months before OLTx. Forty-four patients (47%) had 
ascites. Twenty-one (23%) had suffered at least one 
episode of variceal bleeding, and 28 (30%) had had clin-
ically evident hepatic encephalopathy pretransplanta-
tion. 
The underlying hepatic diseases for which OL Tx was 
performed are given in Table 1. If a patient was trans-
planted for a hepatic malignancy superimposed upon a 
nonmalignant condition (e.g., hepatocellular carcinoma 
arising in a cirrhotic liver), only the malignancy was 
considered for the purpose of analysis. 
Incidence, Types of and Clinical Course of EMBI 
Occurring following OLTx 
A total of 45 individual episodes of EMBI occurred in 
41 of the 93 patients studied. Twenty of the 45 EMBI 
(44%) occurred in the first 2 weeks after OLTx; by the 
first month, 73% of all EMBI episodes had occurred 
(Figure 1). Twenty-nine of the patients (70.7%) who had 
TABLE l. Indications for OLTx in the 93 consecutive patients 
studied 
No. No. No. of Diagnosis of 
surviving EMBI cases 
Primary biliary cirrhosis 27 22 6 
Postnecrotic cirrhosis 20 l.l 13 
Hepatic malignancy" 16 13 6 
Sclerosing cholangitis 13 7 5 
a)-antitrypsin deficiency 3 2 2 
Acute hepatic failure 3 0 2 
Caroli's disease 3 2 
"Lupoid" chronic active hepatitis 2 2 
Hemochromatosis 2 1 1 
Recurrent adenomatosis 1 0 
Venooclusive disease 1 0 . 1 
Wilson's disease 1 1 0 
Cryptococcus cholangitis 0 1 
Total 93 60 41 
a Includes hepatocellular carcinoma (12 cases), fibrolamellar hepa-
toma (2 cases), angiosarcoma (1 case) and cholangiocarcinoma (1 case). 
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WEEKS AFTER TRANSPLANTAT I ON 
FIG. 1. Time of onset of early major bacterial infection after surgery 
in liver transplant recipients. 
EMBI died compared to 4 of the 52 patients -(7.7%) who 
did not develop EMBI after transplantation (p < 0.001). 
Thirty-three of the 93 total patients evaluated (35.5%) 
died during the study period, and in 15 of these (45.4%), 
bacterial infection was the major cause of death. The 
various microorganisms isolated from these patients with 
EMBI are listed in Table 2. Gram-negative bacteria 
predominated over Gram-positive organism. Pseudomo-
nas was isolated from 17 of the 45 cases of EMBI and 
was involved in 9 of the 15 cases in which EMBI con-
tributed to the death of the patient. The types of infec-
tion and their outcome in the patients studied are sum-
marized in Table 2. 
Predictor Factors Analysis 
Risk Factors for EMBI: To determine whether any of 
various preoperative clinical or biochemical factors ob-
tained as part of the pretransplant evaluation could be 
associated with an increased risk of EMBI, factor anal-
ysis was performed and the results of an initial univariate 
analysis are summarized in Table 3. Total bilirubin, IgG, 
total WBC and PMN leukocyte cell count (p < 0.05) and 
creatinine level (p < 0.001) were higher in patients who 
developed post-OLTx bacterial infections than in those 
who did not. The other data analyzed were unrelated 
statistically to the risk of EMBI occurring after OLTx. 
By step-wise discriminant analysis, the strongest risk 
factor for EMBI was the creatinine level, followed in 
order of relative strength by the PMN leukocyte count, 
IgG level, bilirubin level and WBC count (Table 4). 
Preoperative creatinine values greater or lower than 1.52 
mg per dl assigned patients to the infected or noninfected 
group, respectively, with a 68.8% accuracy. Using creat-
inine and a PMN leukocyte count greater than 4,847 per 
mm3, accuracy increased further to 72.1%. With the 
addition of the third step using IgG, accuracy actually 
decreased to 70.5%. 
Predictors of Death: The mortality rate during the 
study period was 35.5%. For the initial analysis, 27 
separate variables were compared between survivors and 
nonsurvivors. As is shown in Table 5, preoperative as-
cites and hepatic encephalopathy were more frequent (p 
< 0.05) in patients who died than in patients who sur-
'ived. Bilirubin and ~qDUtinine levels, WBe connts, 
PMN cell counts all", the helper to suppressor T cell 
TABLE 2. Types and outcome of EMBI in 93 consecu ti ve 
recipients of OL Tx 
No. of 
Type of No. of No. of Agents recovered episodes associated infection episodes patients (No. of times) with 
death" 
Sepsis 18 17 Pseudomonas (9) 14b 
Enterobacter (6) 
Staphylococcus coagulation 
negative (5) 
Klebsiella (3) 
Streptococcus (2) 
E. coli (2) 
Proteus (1) 
Salmonella (1) 
Difteroides (l) 
Pneumonia 16 13 Pseudomonas 15) :3 " 
E. coli (1) 
Legionella (1) 
Unknown (9) 
Pericarditis Legionella 
Abdominal 10 10 Pseudomonas (3) 5' 
abscesses 
Enterobacter (2) 
E. coli (1) 
Unknown (6) 
a Some patients had two or more types of microorganisms. For each 
patient, the full spectrum of clinically significant microbiologic data 
has been entered into the table. 
b Four cases coexisted with fungemia. 
C All of these patients developed sepsis and died because of sepsis. 
ratio were greater (p < 0.05) in patients dying after OLTx 
than they were in those who survived. The remaining 20 
preoperatively obtained variables were statistically un-
related to the risk of mortality after OLTx. 
The results of a step-wise discriminant analysis of 
these variables are shown in Table 6. This analysis 
establishes which of these factors is the most important 
and then ranks them in terms of their relative influence. 
The preoperatively obtained factors that carried an in-
creased risk of death following OL Tx in order of relative 
strength were creatinine, bilirubin, hepatic encephalop-
athy, ascites, WBC and PMN cell counts and the helper 
to suppressor T cell ratio. 
Creatinine values greater or lower than 1. 72 mg per dl 
assigned patients to the nonsurvivor or survivor group, 
respectively, with a 79.1% accuracy. Using bilirubin 
levels, the second factor in order of relative strength, 
accuracy, decreased to 76.1 %. Thus, it is evident that the 
preoperative creatinine level is the major clinical variable 
useful in predicting postoperative survival following 
OLTx. 
DISCUSSION 
The prognosis following OLTx has steadily improved 
during the last 20 years since Starzl first performed the 
procedure in a human being. Progress in defining the 
relative indications and contraindications for OL Tx, re-
finements in the surgical technique, improved methods 
for diagnosing and treating rejection and more effective 
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TAillE 3. 0nivariate analysis of ::isk f",,,,,)rs for each bacterial infection ci'ter OLTx 
Postoperative No postoperative Significance 
level Risk factor 
Age (Y1') 
Sex (male/female i 
Previous infection" 
Previous immunosuppressive therapy· 
Ascites· 
Variceal bleeding" 
Hepatic encephalopathy· 
Total bilirubin level· (mg/dl) 
Prothrombin time (sec)" 
Total serum proteins (mg/dU b 
Serum albumin (mg/dl)b 
Transferrin tug/ dl) b 
EMBI 
(n = 41) 
34 ± 1.4 
:21/20 
23% 
28% 
61% 
33% 
42% 
21.9 ± 2.4 
15.7 ± 0.5 
6.5 ± 0.2 
3.1 ± 0.1 
343 ± 15 
EMBI" 
(n = 52) 
36 ± 1.4 
16/36 
13% 
17% 
47% 
21% 
28% 
14.2 ± 1.8 p < 0.05 
16.7 ± 2.2 
7.1 ± 0.2 
3.4 ± 0.1 
345 ± 14 
WBC count (cells/mm3)b 8,799 ± 866 6,680 ± 520 p < 0.05 
p < 0.05 PMN cell count (cells/mm")" 6,223 ± 685 4,235 ± 341 
Lymphocytes (cells/mm3 ) h 1,122 ± 140 1,242 ± 109 
Lymphocyte T cells (cells/mm")b 604 ± 90 659 ± 50 
189 ± 26 189 ± 22 
423 ± 59 477 ± 33 
2.87 ± 0.26 3.68 ± 0.33 
Helper T lymphocytes (cells/mm3)b 
Suppressor T lymphocytes (cells/mm3)b 
Ratio of helper to suppressor T lymphocytesb 
IgG (mg/dl)b 1,655 ± 129 1,343 ± 70 p < 0.05 
IgM (mg/dl)b 
IgA (mg/dl)b 
C'3 (mg/dl) 
C'4 (mg/dl) 
CHIOO b 
PFB (mg/dl) 
Creatinine (mg/dl) 
• Between first complaint and transplantation. 
b Preoperative evaluation. 
TABLE 4. Step-wise discriminant of risk factors of EMBI 
Risk factor for EMBI" Step Discriminant Accuracy 
value (%) 
Creatinine (mg/dl) ~1KRO mg% 68.8 
PMN cells (cells/mm') 2 ~4IU4T cells/mm' 72.1 
IgG (mg/dl) 3 ~1IR4S mg/dl 70.5 
Bilirubin (mg/dl) 4 ~1UKOU mg/dl 68.9 
WBCs (cells/mm') 5 ~TIO11 cells/mm' 62.3 
a In order of highest to lowest relative strength. 
protocols to treat posttransplantation complications 
have resulted in establishing this procedure as an impor-
tant addition to the clinical management of patients with 
chronic advanced liver disease. As the result of these 
accomplishments, OL Tx is viewed currently as a rational 
long-term treatment for selected patients who have end-
stage liver disease and would otherwise surely die. 
The indications for liver transplantation, like those 
for any other surgical procedure, will vary and continue 
to evolve as success with the procedure improves. But 
because human and economic resources are limited, liver 
transplantation should be restricted, at least initially, to 
those patients with the greatest possibility of survival 
after the procedure. Thus, the selection of appropriate 
candidates for OL Tx is a very important issue of interest 
to surgeons and physicians in an effort to delete from 
the cohort of potential candidates for the procedure those 
who will not survive the effort. 
284 ± 30 316 ± 26 
372 ± 42 351 ± 27 
109 ± 10 123 ± 10 
18 ± 2 24 ± 3 
48 ± ~ 72 ± 6 
32 ± 3 42 ± 8 
2.3 ± 0.4 1.3 ± 0.3 p < 0.001 
The prognosis for survival after OL Tx surgery for any 
individual patient is not easily determined prior to the 
procedure. However, the availability of sophisticated 
methods of analysis and a large patient-specific database 
obtained prior to performance of the procedure makes 
attempts at such prognostication possible. 
Child's classification remains the most successful fac-
tor in predicting the operative mortality and estimating 
the surgical risk accrued in patients undergoing porta-
systemic shunting procedures (8, 9). Elevated preopera-
tive bilirubin levels and the presence of peroperative 
ascites have been shown to differentiate between proba-
ble survivors and nonsurvivors in several studies exam-
ining the prognosis of nonshunt laparotomy in cirrhotic 
patients (9). Previous studies by our own group have 
shown that the plasma levels of several thyroid hor-
mones, T 3, T 4 and rT 3, are important predictors of sur-
vival long enough to experience a transplant (10). The 
present study differs markedly from this earlier one, 
however, in that the population studied is quite different 
(those patients actually transplanted vs. those patients 
evaluated for transplantation), and the endpoints are 
very different (EMBI and survival after OLTx vs. sur-
vivallong enough to have a transplant) (10). 
To assess the risk factors associated with death and 
the development of a bacterial infection postoperatively, 
the latter being the most common fatal complication 
known to occur in adult patients undergoing liver trans-
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TABLE 5. Risk factors for death in adult patients after liver transplantation 
Risk factor Survivors N onsurvivors p value (n = 60) (n=33) 
Age (yr) 36.0 ± 1.3 33.0 ± 1.7 
Sex (male/female) 
Previous infection" 
Previous immunosuppressive therapy" 
Ascites· 
Variceal bleeding" 
22/38 
16% 
24% 
51% 
21% 
24% 
16/17 
22% 
25% 
71% <0.05 
42% 
58% Hepatic encephalopathy· 
Total bilirubin level (mg/dl)b 
Prothrombin time (sec b) 
14.1 ± 1.7 25.8 ± 1.7 
<0.05 
<0.01 
16.4 ± 1.8 16.2 ± 0.6 
Total serum proteins (mg/dl)b 
Serum albumin (mg/dl)b 
Transferrin (Ilg/dl)b 
7.1 ± 0.2 
3.3 ± 0.1 
352 ± 13 
6,4 ± 0.2 
3.1 ± 0.1 
328 ± 18 
WBC count (cells/mm")b 
PMN leukocytes (cells/mm") 
6,882 ± 473 9,157 ± 1,068 <0.05 
<0.05 4,480 ± 306 6,497 ± 866 
Total lymphocyte count (cells/mm")h 
Total T lymphocytes (cells/mm')h 
1,248 ± 97 1,051) ± 171 
613 ± 47 672 ± 114 
181 ± 20 211 ± 31 
429 ± 29 490 ± 80 
3.7 ± 0.3 2.3 ± 0.2 <0.05 
Helper T lymphcytes (cells/mm3)h 
Suppressor T lymphocytes (cells/mm3)b 
Helper to suppressor T lymphocytes ratio b 
IgG (mg/dl)b 1,432 ± 82 1,567 ± 130 
IgM (mg/dl)b 
IgA (mg/dl)b 
C'3 (mg/dl) 
C'4 (mg/dl) 
CHI00· 
PFB (mg/dl) 
Plasma creatinine (mg/dl)b 
" Between first complaint and transplantation. 
b Preoperative evaluation. 
311 ± 23 
370 ± 29 
120 ± 9 
23 ± 2 
68 ± 6 
42 ± 4 
1.3 ± 0.2 
288 ± 38 
340 ± 42 
106 ± 11 
19 ± 2 
45 ± 4 
30 ± 3 
2.7 ± 0.4 <0.05 
TABLE 6. Step-wise discriminant analysis of risk factors for death occurring after liver transplantation 
Positive Negative Accuracy Risk factor for death· Step Discriminant value . Sensitivity Specificity predictive predictive (%) 
Creatinine (mg/dl) 1 2:1.7 mg% 52 
Bilirubin (mg/dl) 2 2:18.66 mg% 57 
Encephalopathy 3 57 
Ascites 4 57 
WBCs (cells/mm3) 5 2:7,632 (cells/mm3) 57 
PMN leukocytes (cells! 6 2:1,300 (cells/mm3) 57 
mm") 
a In order of highest to lowest relative strength. 
plantation (2), we reviewed the clinical and laboratory 
data obtained at admission from 93 consecutive adults 
who underwent liver transplantation at our institution. 
Because our analysis was retrospective, it should be 
remembered that there is a risk that some of our findings 
may be accidental. 
Moreover because the pathogenesis of the variables 
examined are quite different in the various conditions 
studied (Table 1), it must be remembered that the current 
results represent mean observations for a wide spectrum 
of hepatic diseases, and as a result, the data obtained 
from this large unselected disease group may not apply 
directly to those in the smaller more selective disease 
groups. Certainly, it is well known that selected prognos-
tic variables for mortality in primary biliary cirrhosis 
and alcoholic liver disease are not the same (11-13). 
Nonetheless, V" fnund seven preoperative variables 
value value 
96 73 81 79 
85 63 81 76 
85 63 81 76 
85 63 81 76 
87 67 82 76 
85 63 81 76 
that differentiated between survivors and nonsurvivors 
in patients undergoing liver transplantation. These vari-
abIes included the presence of ascites and hepatic en-
cephalopathy, elevated WBC and PMN leukocyte 
counts, bilirubin and creatinine levels, and a decreased 
helper to suppressor T lymphocyte ratio. However, when 
each of these seven preoperative variables was subjected 
to step-wise multivariant discriminant analysis, the 
plasma creatinine level was found to be the best predictor 
of survival or death. Using a properative creatinine level 
as the only predictor, a postoperative death could be 
predicted with an accuracy of 79% for those candidates 
with a creatinine level greater than 1. 72 mg%. Adding 
the predictor effect of the second strongest factor, the 
total bilirubin level actually decreased the accuracy of 
the prediction to 76.1 %. 
As part of this analysis, we also have Bttempted to 
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relate the risk 01 c' posttransplantation bacterial infec-
tion with the same baseline clinical and laboratory data, 
with major infection being the endpoint. Only five pre-
operative variables (bilirubin, WBC and PMN leukocyte 
counts, IgG level and the creatinine level) were greater 
in patients who developed posttransplantation bacterial 
infections than in those who did not. The greatest risk 
factor for EMBI was the creatinine level, followed by the 
PMN leukocyte count. The risk of EMBI could be pre-
dicted with an accuracy of 72.2%. 
In contrast with a previous report (14), we have not 
found the preoperative lymphocyte count, an indirect 
index of host resistance, to be useful index for predicting 
the development of a postoperative bacterial infection. 
In the same way, the helper to suppressor lymphocyte 
ratio, a reflection of the level of function of the cell-
mediated immune system, was of no value in predicting 
the risk of a posttransplantation EMBI. 
In conclusion, our results suggest that the preoperative 
creatinine level provides the best guide to the short-term 
prognosis of a given patient following OL Tx. As a result, 
and based upon our earlier work (10), we believe that 
among a group of potential transplant candidates, the 
creatinine level and the level of various thyroid hormones 
in serum should be used to select the best candidates for 
liver transplantation. 
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